{"cdcTestId":"2013-0299","testcaseName":"#3 at 14 weeks-5 days","vaccineGroup":"HIB","evaluationTestType":"Age: Below Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-07-18T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-08-25T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-22T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Not Valid","evaluationReason":"Age: Too Young"}]},"forecast":{"forecastNum":"3","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2023-01-18T00:00:00","pastDueDate":"2023-03-17T00:00:00"},"doses":[{"dateAdministered":"2022-08-25T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-22T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Not Valid","evaluationReason":"Age: Too Young"}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-22T12:29:38.285","generalDescription":"This test case describes when a child is administered the third dose of the Hib vaccine at an interval of 14 weeks - 5 days after the second dose that the dose is not valid.   A repeat dose should be forecast.","changedInVersion":"1.1","reasonForChange":"Changed Doses 2 and 3 to be ACTHIB rather than PRP-OMP vaccines to avoid possible confusion with PRP-OMP product specific schedule"}